Closed · CDC-RFA-GH21-2143 · CFDA 93.067 · Discretionary
Strengthening HIV Treatment, Laboratory Services, Medication Assisted Therapy, and Program Monitoring in Ukraine under the President's Emergency Plan for AIDS Relief (PEPFAR)
Federal grant opportunity posted by Centers for Disease Control - CGH, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- May 28, 2021
- Close date
- 1
- Expected awards
The verdict
Strengthening HIV Treatment, Laboratory Services, Medication Assisted Therapy, and Program Monitoring in Ukraine under the President's Emergency Plan for AIDS Relief (PEPFAR) is a closed discretionary listing from Centers for Disease Control - CGH that offered Varies by applicant across 1 expected award. Future funding cycles may be published under the same CFDA number.
- Varies
- award range
- Closed
- application status
- 1
- expected award
- 93.067
- CFDA program
Opportunity snapshot. This Grants.gov announcement - Strengthening HIV Treatment, Laboratory Services, Medication Assisted Therapy, and Program Monitoring in Ukraine under the President's Emergency Plan for AIDS Relief (PEPFAR) - is cataloged under number CDC-RFA-GH21-2143 and tied to CFDA assistance listing 93.067, posted by Centers for Disease Control - CGH. Grants.gov currently shows the opportunity as closed, first posted on March 29, 2021. The funding category is Discretionary, delivered as a cooperative agreement.
Award economics. The award range on file is Varies by applicant. It expects to issue 1 award. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on May 28, 2021. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
Varies by applicant
Close Date
May 28, 2021
Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Posted
March 29, 2021
Expected Awards
1
Instrument
Cooperative Agreement
Description
The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $3,000,000 for Year 1, subject to the availability of funds. The HIV epidemic in Ukraine predominantly impacts key populations (KPs) with the largest burden among people who inject drugs (PWID) and men who have sex with men (MSM). There are approximately 220,000 people living with HIV (PLHIV) in Ukraine. PEPFAR has been providing technical support to Ukraine to scale up index testing and for sexual and needle-sharing partners, social network testing, and increased access to pre-exposure prophylaxis (PrEP) and medicated assisted therapy for PWID. PEPFAR has also been supporting improved access to World Health Organization (WHO) recommended first line antiretroviral therapies (ARTs) and delivery strategies to improve retention and viral suppression. This NOFO will create an enabling policy environment and full implementation of the HIV electronic data entry system (HIV MIS). The strategies include providing technical assistance (TA) for HIV testing and treatment providers to enhance care and treatment, to create a National Medical Assisted Therapy (MAT) Hub to ensure government leadership in MAT scale up and enhance laboratory capacity. The assistance provided will ensure national level strengthening of surveillance, research, and epidemiology (SRE) by focusing on improved HIV case-based, mortality, surveillance, epidemic modelling, routine KP cascade based on program and medical data, and HIV drug resistance (DR). All activities will build capacity and contribute to achieving 95-95-95 targets and maintain epidemic control in Ukraine.
Eligibility
Grants.gov lists this opportunity under eligibility category code 25. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Parent Grant Program
Global AIDS
U.S. Department of Health and Human Services
Agency Contact
Emily Dale dln6@cdc.gov
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |